1. CMU Intellectual Repository

Browsing by Author Laongdao Thongnak

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 15 of 15
Issue DateTitleAuthor(s)
1-Dec-2017The additive effects of atorvastatin and insulin on renal function and renal organic anion transporter 3 function in diabetic ratsLaongdao Thongnak; Anchalee Pongchaidecha; Krit Jaikumkao; Varanuj Chatsudthipong; Nipon Chattipakorn; Anusorn Lungkaphin
15-Aug-2021Agomelatine protects against obesity-induced renal injury by inhibiting endoplasmic reticulum stress/apoptosis pathway in ratsRada Cherngwelling; Nattavadee Pengrattanachot; Myat Theingi Swe; Laongdao Thongnak; Sasivimon Promsan; Nichakorn Phengpol; Prempree Sutthasupha; Anusorn Lungkaphin
1-Jul-2022Agomelatine, a structural analog of melatonin, improves kidney dysfunction through regulating the AMPK/mTOR signaling pathway to promote autophagy in obese ratsSasivimon Promsan; Laongdao Thongnak; Nattavadee Pengrattanachot; Nichakorn Phengpol; Prempree Sutthasupha; Anusorn Lungkaphin
1-Sep-2021Anthocyanin-rich fraction from black rice, Oryza sativa L. var. indica “Luem Pua,” bran extract attenuates kidney injury induced by high-fat diet involving oxidative stress and apoptosis in obese ratsPongrapee Laorodphun; Phatchawan Arjinajarn; Laongdao Thongnak; Sasivimon Promsan; Myat Theingi Swe; Pasin Thitisut; Sugunya Mahatheeranont; Sanchai Jaturasitha; Anusorn Lungkaphin
1-Jun-2020Atorvastatin attenuates obese-induced kidney injury and impaired renal organic anion transporter 3 function through inhibition of oxidative stress and inflammationNattavadee Pengrattanachot; Rada Cherngwelling; Krit Jaikumkao; Anchalee Pongchaidecha; Laongdao Thongnak; Myat Theingi Swe; Varanuj Chatsudthipong; Anusorn Lungkaphin
15-Jul-2022Chitosan oligosaccharide mitigates kidney injury in prediabetic rats by improving intestinal barrier and renal autophagyPrempree Sutthasupha; Sasivimon Promsan; Laongdao Thongnak; Nattavadee Pengrattanachot; Nichakorn Phengpol; Onanong Jaruan; Krit Jaikumkao; Chatchai Muanprasat; Rath Pichyangkura; Varanuj Chatsudthipong; Anusorn Lungkaphin
1-Apr-2022The combination of dapagliflozin and statins ameliorates renal injury through attenuating the activation of inflammasome-mediated autophagy in insulin-resistant ratsLaongdao Thongnak; Nattavadee Pengrattanachot; Sasivimon Promsan; Nichakorn Phengpol; Prempree Sutthasupha; Varanuj Chatsudthipong; Anusorn Lungkaphin
1-Sep-2021Dapagliflozin ameliorates pancreatic injury and activates kidney autophagy by modulating the AMPK/mTOR signaling pathway in obese ratsKrit Jaikumkao; Sasivimon Promsan; Laongdao Thongnak; Myat T. Swe; Monruedee Tapanya; Khin T. Htun; Suchart Kothan; Nuttawadee Intachai; Anusorn Lungkaphin
1-May-2020Dapagliflozin attenuates renal gluconeogenic enzyme expression in obese ratsMyat Theingi Swe; Laongdao Thongnak; Krit Jaikumkao; Anchalee Pongchaidecha; Varanuj Chatsudthipong; Anusorn Lungkaphin
1-Jan-2019Dapagliflozin not only improves hepatic injury and pancreatic endoplasmic reticulum stress, but also induces hepatic gluconeogenic enzymes expression in obese ratsMyat Theingi Swe; Laongdao Thongnak; Krit Jaikumkao; Anchalee Pongchaidecha; Varanuj Chatsudthipong; Anusorn Lungkaphin
1-Jun-2020Effects of dapagliflozin and statins attenuate renal injury and liver steatosis in high-fat/high-fructose diet-induced insulin resistant ratsLaongdao Thongnak; Varanuj Chatsudthipong; Aphisek Kongkaew; Anusorn Lungkaphin
10-May-2022The impact of prebiotic fructooligosaccharides on gut dysbiosis and inflammation in obesity and diabetes related kidney diseaseNattavadee Pengrattanachot; Laongdao Thongnak; Anusorn Lungkaphin
1-Sep-2020Mitigation of renal inflammation and endoplasmic reticulum stress by vildagliptin and statins in high-fat high-fructose diet-induced insulin resistance and renal injury in ratsLaongdao Thongnak; Varanuj Chatsudthipong; Anusorn Lungkaphin
1-Feb-2020Renal Lipid Metabolism and Lipotoxicity in DiabetesLaongdao Thongnak; Anchalee Pongchaidecha; Anusorn Lungkaphin
1-Jun-2018Renal outcomes with sodium glucose cotransporter 2 (SGLT2) inhibitor, dapagliflozin, in obese insulin-resistant modelKrit Jaikumkao; Anchalee Pongchaidecha; Nuttawud Chueakula; Laongdao Thongnak; Keerati Wanchai; Varanuj Chatsudthipong; Nipon Chattipakorn; Anusorn Lungkaphin
Showing results 1 to 15 of 15